Review
Published on 16 Jan 2025
Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1522491
- 1,082 views
- 1 citation
Type at least 3 characters
1,822 articles
Original Research
Published on 07 Jan 2025
Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1494384
- 898 views
Original Research
Published on 07 Jan 2025
Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1414950
- 1,409 views
Systematic Review
Published on 07 Jan 2025
The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1478888
- 1,410 views
Editorial
Published on 06 Jan 2025
Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1542306
- 533 views
Original Research
Published on 06 Jan 2025
Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1481713
- 1,014 views
Original Research
Published on 06 Jan 2025
Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1508112
- 1,097 views
Original Research
Published on 06 Jan 2025
Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1504809
- 708 views
Case Report
Published on 06 Jan 2025
Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407893
- 521 views
Review
Published on 24 Dec 2024
BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1463505
- 1,241 views
Case Report
Published on 19 Dec 2024
Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1477697
- 1,055 views
Case Report
Published on 17 Dec 2024
Obinutuzumab-induced acute thrombocytopenia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1509567
- 914 views
Clinical Trial
Published on 16 Dec 2024
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1449401
- 1,138 views
Case Report
Published on 12 Dec 2024
Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1518387
- 605 views
Correction
Published on 11 Dec 2024
Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1504102
- 508 views
Case Report
Published on 11 Dec 2024
Preoperative diagnosis of primary ovarian lymphoma: a case report and a decade of insights
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1471654
- 570 views